Literature DB >> 23417900

Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.

Norbert Varga1, Ieva Sutkeviciute, Cinzia Guzzi, John McGeagh, Isabelle Petit-Haertlein, Serena Gugliotta, Jörg Weiser, Jesús Angulo, Franck Fieschi, Anna Bernardi.   

Abstract

Dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) and Langerin are C-type lectins of dendritic cells (DCs) that share a specificity for mannose and are involved in pathogen recognition. HIV is known to use DC-SIGN on DCs to facilitate transinfection of T-cells. Langerin, on the contrary, contributes to virus elimination; therefore, the inhibition of this latter receptor is undesired. Glycomimetic molecules targeting DC-SIGN have been reported as promising agents for the inhibition of viral infections and for the modulation of immune responses mediated by DC-SIGN. We show here for the first time that glycomimetics based on a mannose anchor can be tuned to selectively inhibit DC-SIGN over Langerin. Based on structural and binding studies of a mannobioside mimic previously described by us (2), a focused library of derivatives was designed. The optimized synthesis gave fast and efficient access to a group of bis(amides), decorated with an azide-terminated tether allowing further conjugation. SPR inhibition tests showed improvements over the parent pseudomannobioside by a factor of 3-4. A dimeric, macrocyclic structure (11) was also serendipitously obtained, which afforded a 30-fold gain over the starting compound (2). The same ligands were tested against Langerin and found to exhibit high selectivity towards DC-SIGN. Structural studies using saturation transfer difference NMR spectroscopy (STD-NMR) were performed to analyze the binding mode of one representative library member with DC-SIGN. Despite the overlap of some signals, it was established that the new ligand interacts with the protein in the same fashion as the parent pseudodisaccharide. The two aromatic amide moieties showed relatively high saturation in the STD spectrum, which suggests that the improved potency of the bis(amides) over the parent dimethyl ester can be attributed to lipophilic interactions between the aromatic groups of the ligand and the binding site of DC-SIGN.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23417900     DOI: 10.1002/chem.201202764

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  10 in total

Review 1.  Targeting the C-type lectins-mediated host-pathogen interactions with dextran.

Authors:  Sergey Pustylnikov; Divya Sagar; Pooja Jain; Zafar K Khan
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

Review 2.  Recent insights into structures and functions of C-type lectins in the immune system.

Authors:  Kurt Drickamer; Maureen E Taylor
Journal:  Curr Opin Struct Biol       Date:  2015-07-07       Impact factor: 6.809

3.  On-Chip Screening of a Glycomimetic Library with C-Type Lectins Reveals Structural Features Responsible for Preferential Binding of Dectin-2 over DC-SIGN/R and Langerin.

Authors:  Laura Medve; Silvia Achilli; Sonia Serna; Fabio Zuccotto; Norbert Varga; Michel Thépaut; Monica Civera; Corinne Vivès; Franck Fieschi; Niels Reichardt; Anna Bernardi
Journal:  Chemistry       Date:  2018-09-03       Impact factor: 5.236

4.  Enhancing Potency and Selectivity of a DC-SIGN Glycomimetic Ligand by Fragment-Based Design: Structural Basis.

Authors:  Laura Medve; Silvia Achilli; Joan Guzman-Caldentey; Michel Thépaut; Luca Senaldi; Aline Le Roy; Sara Sattin; Christine Ebel; Corinne Vivès; Sonsoles Martin-Santamaria; Anna Bernardi; Franck Fieschi
Journal:  Chemistry       Date:  2019-10-18       Impact factor: 5.236

Review 5.  Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN.

Authors:  Jonathan Cramer
Journal:  RSC Med Chem       Date:  2021-09-16

6.  Targeted delivery to macrophages and dendritic cells by chemically modified mannose ligand-conjugated siRNA.

Authors:  Keiji Uehara; Toshimasa Harumoto; Asana Makino; Yasuo Koda; Junko Iwano; Yasuhiro Suzuki; Mari Tanigawa; Hiroto Iwai; Kana Asano; Kana Kurihara; Akinori Hamaguchi; Hiroshi Kodaira; Toshiyuki Atsumi; Yoji Yamada; Kazuma Tomizuka
Journal:  Nucleic Acids Res       Date:  2022-05-20       Impact factor: 19.160

7.  Pseudo-mannosylated DC-SIGN ligands as potential adjuvants for HIV vaccines.

Authors:  Angela Berzi; Norbert Varga; Sara Sattin; Patrizio Antonazzo; Mara Biasin; Irene Cetin; Daria Trabattoni; Anna Bernardi; Mario Clerici
Journal:  Viruses       Date:  2014-01-27       Impact factor: 5.048

8.  Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions.

Authors:  Yuan Guo; Chadamas Sakonsinsiri; Inga Nehlmeier; Martin A Fascione; Haiyan Zhang; Weili Wang; Stefan Pöhlmann; W Bruce Turnbull; Dejian Zhou
Journal:  Angew Chem Int Ed Engl       Date:  2016-03-16       Impact factor: 15.336

9.  Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions.

Authors:  Yuan Guo; Chadamas Sakonsinsiri; Inga Nehlmeier; Martin A Fascione; Haiyan Zhang; Weili Wang; Stefan Pöhlmann; W Bruce Turnbull; Dejian Zhou
Journal:  Angew Chem Weinheim Bergstr Ger       Date:  2016-03-15

Review 10.  Molecular Recognition in C-Type Lectins: The Cases of DC-SIGN, Langerin, MGL, and L-Sectin.

Authors:  Pablo Valverde; J Daniel Martínez; F Javier Cañada; Ana Ardá; Jesús Jiménez-Barbero
Journal:  Chembiochem       Date:  2020-07-02       Impact factor: 3.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.